We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 5.56% | 19.00 | 17.50 | 19.00 | 18.25 | 17.75 | 18.00 | 265,059 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/5/2017 13:11 | Diamond is that your best guess? | rafboy | |
18/5/2017 13:11 | Just had my first Lush Banana shake as a lunch replacement. Didn't taste too bad at all. Now let's see if I can get to dinner without snacking, apart from a Cacoa Orange flapjack bar of course! | zedder | |
18/5/2017 13:10 | Just arrived from penny share Optibiotix has launched its slimming and anti-cholesterol products at a big trade fair in Geneva. Apparently OPTI's stand was swamped with interest: "Both LPLDL® and SlimBiome® were extremely well received with high interest in the distribution and sale of these products from partners across Europe, Japan, India, Asia, Australia and the USA." The most interesting news is in the quote from Stephen O'Hara: "We are extremely pleased with the very high level of interest from both national and multinational companies interested in selling our products. This has already resulted in some companies sending through draft contracts." (emphasis mine) We're waiting for a big food company to start making products based on OPTI's science, that's the basic play here. When a deal like that happens, it could transform the share price, since OPTI's cost base is extremely low. We've been waiting for the deal for a few months now. But this week's news seems to show that things are moving along. OPTI is still a BUY. | pglancy | |
18/5/2017 13:04 | monkeywench118 May '17 - 12:50 - 23758 of 23761 0 0 (Filtered) Just to clarify so you dont make the same mistake as you did on the prism bb. I can see your username but nothing of the war and peace posts you write. lol | incanus | |
18/5/2017 13:02 | Shrewd monkey and research to go in the same sentence. Look at his history, you have to go back months to find a cust & paste quote on financials on the biome bb. That was it, the rest, lol, rampers, etc. You are powerless because of his premium status which is why so many advocate using the filter and most have i guess. Including me as of now. | incanus | |
18/5/2017 12:57 | Moneywench Any meaningful input? Any research into the microbiome arena, potential earnings or level 2 indicators? S | shrewdmole | |
18/5/2017 12:49 | Monkey and MM on tother thread are treated in equal disdain and used a distraction during news gaps. No doubt they both think highly of themselves and think we hang on every word. The major bulls have gone very quiet here. Come out, come out wherever you are. You're missed. | incanus | |
18/5/2017 12:36 | Moneymouse it should be as he knows so much! | shrewdmole | |
18/5/2017 12:12 | 75p appears to be the hurdle. | incanus | |
18/5/2017 12:03 | One thing we agree on monkey. It's just a shame you are going to use it as your excuse for carrying with your bullying campaign regardless. I note your tactic to avoid being called a ramper, your favourite term, is avoid posting any research of your own. End of discussion, bully. | incanus | |
18/5/2017 11:28 | LOL @ Monkeymouse | loungeact | |
18/5/2017 11:16 | Sienna Ramping (the market): "Actions designed to artificially raise the market price of listed securities and to give the impression of voluminous trading, in order to make a quick profit I think that just about sums up most of the posters on here. | monkeywench1 | |
18/5/2017 10:49 | I am liking these 7.5K trades within seconds of each other - new insti's loading up? | parob | |
18/5/2017 10:46 | SBTX, four free shares for every ten OPTIBIOTIX shares held? DIAMOND. | diamond fibre | |
18/5/2017 09:43 | A 40K buy went through nex earlier... | parob | |
18/5/2017 09:39 | hxxps://masterinvest Optibiotix: Broadening triangle still promises 100p while above 60p By Zak Mir 16 May 2017 1 mins. to read I have asked the CEO of Optibiotix (LON:OPTI) to investigate one of the world’s most serious afflictions, male pattern baldness, now that the health supplements area appears to have been cracked… Given how much has been happening at Optibiotix since the end of 2015, it would appear somewhat churlish of the market not to regard the company as being more valuable than it was nearly a year and a half ago. This point is particularly underlined in the wake of the latest from the company regarding the “exciting̶ Of course, the name of the game for the life sciences group is to commercialise its offerings and turn revenues into profits. It would appear that while we may be looking at quite a cutting edge company in terms of the science, for investors it is all about the bottom line. However, with the prospect of products such as CholBiome, CardioBiome and a sweet fibre which could be an alternative to the dreaded sugar, Optibiome has plenty of fundamental strings to its bow. As far as the technical picture is concerned it can be seen how the stock has just bounced off the floor of a broadening triangle, a somewhat frustratingly long lived feature. But at least while we hold above the floor of the triangle at 60p, the top of the feature at 100p could be a viable 3-6 months time frame target. | scotty1 | |
18/5/2017 09:34 | About to go blue i reckon. | scotty1 | |
18/5/2017 09:33 | When is this 10k seller going to take a day off? | wardy333 | |
18/5/2017 08:39 | Exactly rafboy, and we know that's SOH's aim! | parob | |
18/5/2017 08:37 | At least with the SBTX share price rising our free shares will be worth more. | rafboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions